Helen Torley - Insider Trading & Ownership

Location
C/O Onyx Pharmaceuticals, Inc., 249 East Grand Ave., South San Francisco, CA
Summary
The estimated net worth of Helen Torley is at least $58.7M dollars as of November 12, 2025. Helen Torley is the PRESIDENT AND CEO, Director of HALOZYME THERAPEUTICS, INC. and owns shares of HALOZYME THERAPEUTICS, INC. (HALO) stock worth about $58M. Helen Torley is the Director of QUEST DIAGNOSTICS INC and owns shares of QUEST DIAGNOSTICS INC (DGX) stock worth about $769K.
Signature
/s/ James R. Oehler, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Helen Torley

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HALO HALOZYME THERAPEUTICS, INC. PRESIDENT AND CEO, Director $58M -$23.3M -28.7% Nov 10, 2025
DGX QUEST DIAGNOSTICS INC Director $769K May 25, 2021

Insider Transactions Reported by Helen Torley:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.